Geoffrey Hodge, chief executive officer of SOTIO Biotech US, discussed the company's development of the BOXR cell therapy platform.
Geoffrey Hodge
Advertisement
Articles by Geoffrey Hodge
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Slams REGENXBIO's MPS II Gene Therapy RGX-121 With CRL
2
Around the Helix: Cell and Gene Therapy Company Updates – February 11, 2026
3
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
4
Guess the Therapy Answer February 11, 2026
5